Medtronic has launched the Intellis platform with a small implantable spinal cord stimulator for the management of select types of chronic intractable pain in the US.

Following approval from the US Food and Drug Administration (FDA), the Intellis device was implanted in the first patient at the Duke University Medical Centre in North Carolina.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Intended to address the limitations with existing spinal cord stimulation (SCS) systems, the new device leverages the Evolve workflow to balance high-dose (HD) and low-dose (LD) therapy settings.

Medtronic Pain Therapies division senior vice-president and president Marshall Stanton said: “Drawing upon our 40-year legacy in SCS, the launch of the Intellis platform isn't just about a new device, but about combining cutting-edge hardware with optimal therapy through the Evolve workflow to enable personalised, long-term pain relief.

"The Intellis platform tracks and shares the information on daily activities, body positions and therapy usage to optimise treatment and improve communication."

“We considered the entire patient journey starting with the primary goal of optimal pain relief and access to important diagnostic tools, like MRI, to ease of use with simplified programming, faster recharge and a smaller implant.”

The Intellis platform tracks and shares the information on daily activities, body positions and therapy usage to optimise treatment and improve communication between the patient and physician.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

It features the firm’s Overdrive battery technology that enables complete recharge in around one hour, SureScan MRI technology for MRI scanning anywhere on the body under select conditions, and AdaptiveStim technology to automatically adjust accurate dose delivery.

The device can be managed on the Samsung Galaxy Tab S2 tablet interface and allows physicians to monitor progress or make modifications to the therapy based on patient needs.

Image: Medtronic's Intellis spinal cord stimulation platform. Photo: courtesy of Medtronic plc.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact